Literature DB >> 19615014

Fibroblastic rheumatism: fibromatosis rather than non-Langerhans cell histiocytosis.

Nicolas Kluger1, Alexandra Dumas-Tesici, Dominique Hamel, Nicole Brousse, Sylvie Fraitag.   

Abstract

BACKGROUND: Fibroblastic rheumatism is a unique fibro-proliferative disease affecting the skin and joints. It is characterized by distinctive clinical and histological features related to benign spindle-shaped cells proliferation. Pediatric reports are scarce in the literature.
OBJECTIVE: We describe here a new case in a 10-year-old boy and discuss the potential origin of the cell proliferation.
METHODS: Clinical findings, radiology, microscopic examination and outcome are reviewed. Histopathology and immunochemistry studies were performed on skin biospies using CD68, CD163, desmin, factor XIIIa, CD34, smooth muscle actin, PS100, epithelial membrane antigen, and calponin.
RESULTS: Histological sections disclosed a rather circumscribed nonencapsulated nodular infiltrate, invading the dermis and the upper subcutaneous tissue, consisted of a proliferation of spindle or stellate-shaped cells and thickened collagen fibers. Orcein staining showed disappearance of the elastic network. Aponeurosis and muscle were normal. A mild perivascular lymphohistiocytic infiltrate was noted. Calponin-staining was less strongly expressed as SMA, and some of them but not all were CD68 positive, as well. On the other hand, all were CD34, CD163, FXIIIa, PS100, EMA and desmin-negative.
CONCLUSION: The true origin of these cells remains unclear. Some authors have speculated a histiocytic origin. However, immuno-chemical staining in our case failed to confirm this hypothesis and instead supported a fibroblastic/myofibroblastic origin. Given the clinical course and the histological and immunohistochemical results, we suggest that FR should be added to the group of fibromatoses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615014     DOI: 10.1111/j.1600-0560.2009.01345.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

Review 1.  Fibroblastic rheumatism: an uncommon arthritis. A case-based review.

Authors:  A Pieta; A Zioga; A Skalkou; A I Venetsanopoulou; A A Drosos; P V Voulgari
Journal:  Rheumatol Int       Date:  2021-10-05       Impact factor: 2.631

2.  Response of fibroblastic rheumatism to infliximab.

Authors:  Ricardo Romiti; Mauricio Levy Neto; Marcello Menta Simonsen Nico
Journal:  Dermatol Res Pract       Date:  2010-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.